George Vlahos

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis et al. · British Journal of Cancer · 2012 · 168 citations · Full text

Medicine, Immunology, Oncology +17

VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2

Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas et al. · International Journal of Cancer · 2011 · 168 citations

Medicine, Immunology, Oncology +17

Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy

Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos et al. · Gynecologic Oncology · 2007 · 92 citations

Medicine, Immunology, Oncology +17

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy

Aristotle Bamias, Maria Sotiropoulou, Dimitrios Haidopoulos et al. · Cancer · 2010 · 90 citations · Full text

Medicine, Gynecology, Oncology +17

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance

Aristotelis Bamias, Marinos Tsiatas, Eftychia Kafantari et al. · Gynecologic Oncology · 2007 · 78 citations

Medicine, Immunology, Oncology +15